Virbac SAVirbac SAVirbac SA

Virbac SA

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.87 B‬EUR
18.0EUR
‪150.89 M‬EUR
‪1.46 B‬EUR
‪4.09 M‬
Beta (1Y)
0.81
Employees (FY)
‪6.44 K‬
Change (1Y)
+822 +14.63%
Revenue / Employee (1Y)
‪227.36 K‬EUR
Net income / Employee (1Y)
‪23.42 K‬EUR

About Virbac SA


CEO
Paul Martingell
Website
Headquarters
Carros
Founded
1984
IPO date
Jan 1, 1985
Identifiers
2
ISIN FR0000031577
CFI code
ESVUFN
Virbac SA engages in the manufacture and sale of veterinary medicines. It operates through the following business segments: Companion Animals and Farm Animals. It develops vaccines, antibiotics, anesthetics, dermatological products, and drugs for pest control, inflammation, dental care, and ophthalmological conditions of pets and livestock. It also operates through the following geographical segments: France, Europe, Latin America, North America, Asia, Pacific, and Africa and Middle-East. The Europe segment excludes France. The company was founded by Pierre-Richard Dick and Max Rombi in 1968 and is headquartered in Carros, France.

Check out other big names from the same industry as VIRP.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Weight 0.04%
Market value ‪6.69 M‬
Weight 0.04%
Market value ‪6.48 M‬
Weight 0.01%
Market value ‪4.38 M‬
Weight 0.07%
Market value ‪3.46 M‬
Weight 0.27%
Market value ‪2.86 M‬
Weight 0.04%
Market value ‪2.40 M‬
Weight 7.00%
Market value ‪2.27 M‬

Explore more ETFs 

Frequently asked questions


The current price of VIRP is 346.0 EUR — it hasn't changed in the past 24 hours. Watch Virbac SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange Virbac SA stocks are traded under the ticker VIRP.
VIRP stock has risen by 0.59% compared to the previous week, the month change is a −1.86% fall, over the last year Virbac SA has showed a 8.46% increase.
We've gathered analysts' opinions on Virbac SA future price: according to them, VIRP price has a max estimate of 440.00 EUR and a min estimate of 368.00 EUR. Watch VIRP chart and read a more detailed Virbac SA stock forecast: see what analysts think of Virbac SA and suggest that you do with its stocks.
VIRP reached its all-time high on Nov 1, 2021 with the price of 448.5 EUR, and its all-time low was 5.5 EUR and was reached on Jun 4, 2001. View more price dynamics on VIRP chart.
See other stocks reaching their highest and lowest prices.
VIRP stock is 1.91% volatile and has beta coefficient of 0.81. Track Virbac SA stock price on the chart and check out the list of the most volatile stocks — is Virbac SA there?
Today Virbac SA has the market capitalization of ‪2.87 B‬, it has increased by 0.97% over the last week.
Yes, you can track Virbac SA financials in yearly and quarterly reports right on TradingView.
Virbac SA is going to release the next earnings report on Sep 17, 2026. Keep track of upcoming events with our Earnings Calendar.
VIRP net income for the last half-year is ‪68.48 M‬ EUR, while the previous report showed ‪82.41 M‬ EUR of net income which accounts for 0.00% change. Track more Virbac SA financial stats to get the full picture.
Yes, VIRP dividends are paid annually. The last dividend per share was 1.45 EUR. As of today, Dividend Yield (TTM)% is 0.42%. Tracking Virbac SA dividends might help you take more informed decisions.
Virbac SA dividend yield was 0.41% in 2025, and payout ratio reached 8.05%. The year before the numbers were 0.46% and 8.36% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 12, 2026, the company has ‪6.44 K‬ employees. See our rating of the largest employees — is Virbac SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Virbac SA EBITDA is ‪276.77 M‬ EUR, and current EBITDA margin is 18.90%. See more stats in Virbac SA financial statements.
Like other stocks, VIRP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Virbac SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Virbac SA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Virbac SA stock shows the buy signal. See more of Virbac SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.